Canopy Growth CGC
NASDAQ CGC
$1.02 -0.02 (-1.83%)
At close: Aug 20, 2026 · 10:53 AM UTC

Canopy Growth (CGC) Shares Outstanding (2017 - 2026)

Canopy Growth (CGC) posted Shares Outstanding (Entity) of $298.0 million for Q1 2026, down 19.07% sequentially from $368.3 million in Q4 2025, and up 177.11% YoY from $107.6 million in Q1 2025.

Canopy Growth (CGC) Shares Outstanding (2017 - 2026) Analysis & Trends

Canopy Growth has reported Shares Outstanding (Entity) for 10 years, with the latest figure at $298.0 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 177.11% year-over-year to $298.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $298.0 million (up 177.11% YoY) and the FY2026 annual result came in at $298.0 million, up 177.11% from the prior year.
  • Shares Outstanding (Entity) fell to $298.0 million in Q1 2026 per CGC's latest filing, from $368.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $368.3 million in Q4 2025 and troughed at $39.4 million in Q1 2022.
  • A 5-year average of $123.0 million and a median of $82.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) increased 3.02% in 2022, then soared 191.94% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $49.5 million in 2022, then surged by 67.58% to $82.9 million in 2023, then soared by 55.73% to $129.2 million in 2024, then jumped by 185.15% to $368.3 million in 2025, then dropped by 19.07% to $298.0 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $298.0 million, $368.3 million, and $274.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.76 Bn 42.79 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.38 Bn 39.73 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.61 Bn 29.93 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.64 Bn 22.84 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.20 Bn 19.54 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.82 Bn 17.93 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.67 Bn 15.28 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.11 Bn 11.58 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - 832.44 Mn
10 Canopy Growth 431.13 Mn 184.12 Mn 16.08 Mn 422.26 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 422.26 Mn
Mar 31, 2026 298.04 Mn
Dec 31, 2025 345.53 Mn
Sep 30, 2025 274.03 Mn
Jun 30, 2025 188.32 Mn
Mar 31, 2025 107.55 Mn
Dec 31, 2024 110.31 Mn
Sep 30, 2024 86.83 Mn
Jun 30, 2024 79.24 Mn
Mar 31, 2024 74.79 Mn
Dec 31, 2023 82.92 Mn
Sep 30, 2023 71.63 Mn
Jun 30, 2023 55.05 Mn
Mar 31, 2023 46.37 Mn
Dec 31, 2022 48.61 Mn
Sep 30, 2022 47.16 Mn
Jun 30, 2022 39.85 Mn
Mar 31, 2022 39.13 Mn
Dec 31, 2021 39.38 Mn
Sep 30, 2021 39.33 Mn